de Jong, J.M.; Broekaart, D.W.M.; Bongaarts, A.; Mühlebner, A.; Mills, J.D.; van Vliet, E.A.; Aronica, E.
Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors. Biomedicines 2022, 10, 2475.
https://doi.org/10.3390/biomedicines10102475
AMA Style
de Jong JM, Broekaart DWM, Bongaarts A, Mühlebner A, Mills JD, van Vliet EA, Aronica E.
Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors. Biomedicines. 2022; 10(10):2475.
https://doi.org/10.3390/biomedicines10102475
Chicago/Turabian Style
de Jong, Jody M., Diede W. M. Broekaart, Anika Bongaarts, Angelika Mühlebner, James D. Mills, Erwin A. van Vliet, and Eleonora Aronica.
2022. "Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors" Biomedicines 10, no. 10: 2475.
https://doi.org/10.3390/biomedicines10102475
APA Style
de Jong, J. M., Broekaart, D. W. M., Bongaarts, A., Mühlebner, A., Mills, J. D., van Vliet, E. A., & Aronica, E.
(2022). Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors. Biomedicines, 10(10), 2475.
https://doi.org/10.3390/biomedicines10102475